Empagliflozin and Renal Oxygenation in Healthy Volunteers

NCT03093103 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Nephropathy

Interventions

DRUG: Empagliflozin 10 mg
DRUG: Placebo

Sponsor

Centre Hospitalier Universitaire Vaudois